Both in Pharmaceuticals
Nuvation Bio vs ANI Pharmaceuticals
Over the past year NUVB returned −11.2% and ANIP returned −24.9%; their daily moves had a correlation of 0.02.
NUVB −11.2% ANIP −24.9%Growth of $1, one year, split-adjusted
| Metric | NUVB | ANIP |
|---|---|---|
| Price | $4.59 | $70.67 |
| Market cap | $1.61B | $1.62B |
| Today | −3.57% | −1.85% |
| 1 month | −10.7% | −2.1% |
| 6 months | +4.1% | −14.2% |
| Year to date | −48.8% | −10.5% |
| 1 year | −10.9% | −23.1% |
| Revenue growth (YoY) | +555.6% | +25.9% |
| Gross margin | 73.0% | 62.4% |
| Net margin | −198.3% | 8.6% |
| P/E (TTM) | — | 16.3× |
| Price / sales | 9.5× | 1.7× |
| Net cash | $399.4M | -$234.7M |
| Dividend yield | — | — |
| Volatility (60d) | 50.8% | 27.2% |
| Short % of float | 23.9% | 18.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).